The activities of veterinary vaccine control laboratories are reviewed. The National Veterinary Assay Laboratory (NVAL) in Japan is used as an example to describe a quality control system for veterinary vaccines. 
Introduction
Standards for the quality, efficacy and safety of veterinary vaccines are established by relevant laws and directives in each country or region. Veterinary vaccine control laboratories are established in most countries to ensure that these standards are met. Two examples of such laboratories are the National Centre for Veterinary and Food Studies ('Centre national d'études vétérinaires et alimentaires': CNEVA) in France and the Center for Veterinary Biologics Laboratory in the United States of America (USA). The functions of the veterinary control laboratory are similar in most countries. Due to the familiarity of the author with the Japanese laboratory, this will be used as an example.
In Japan and most other countries, drugs for animal use are controlled by the Ministry of Agriculture. In Japan, control is supervised by the Ministry of Agriculture, Forestry and Fisheries (MAFF), which enforces the Pharmaceutical Affairs Law and relevant regulations (1, 5, 6, 7, 8, 9, 10) . The Ministry of Agriculture in most countries has an office or department that is responsible for veterinary vaccine registration, and these departments usually have an attached laboratory. This laboratory may be a part of the national veterinary laboratory, which is the case in Mexico, Canada, Argentina and a number of other countries. The National Veterinary Assay Laboratory (NVAL) is the veterinary vaccine control laboratory for Japan. The NVAL reports to the Office of Veterinary Drug Administration (OVDA), which is under the direction of the MAFF.
The veterinary vaccine control laboratory (the NVAL in Japan) conducts the national assay of biological products (vaccine, immune serum and diagnostic reagent), as well as providing technical support and consultation on the registration of veterinary vaccines.
Control systems for veterinary vaccines
The following criteria are the main elements of vaccine approval in Japan and many other countries: a) All vaccine that is manufactured in the country or imported must be approved and licensed by the Ministry of Agriculture.
To obtain approval, the manufacturer or importer must The application should include the results of the quality control testing of the master cell line. Furthermore, manufacturers of vaccines in Japan and most other countries cannot obtain a license unless they conform to standards for 'good manufacturing practice' of drugs for animal use.
b)
No vaccine which is not in conformity with the minimum requirements shall be sold, manufactured or imported.
Standards for manufacturing methods, properties and description of the product, quality of the product, method of storage, shelf-life and other components of biological products for animal use are prescribed in the minimum requirements in Japan (2). c) In most, countries, vaccines for animal use must be assayed by the vaccine control laboratory before the product can be sold. The NVAL is designated as the assaying laboratory for biological products in Japan.
d) In Japan, a method for the re-examination of vaccines has been established. Data submitted for approval of a new vaccine is not always adequate, chiefly due to the fact that the vaccine has been tested on a limited number of animals under controlled conditions. Hence, the re-examination system was established in Japan to review the efficacy and safety of a new drug on the basis of results of investigations conducted by manufacturers or importers two or six years after initial approval of the drug.
The re-examination of the data is conducted by the OVDA. The surveillance data submitted with the application for re-examination must be collected and compiled based on the standard for 'good post-marketing surveillance practices' (GPMSP) specified by the Minister. e) In Japan, when it is suspected that the quality, efficacy and safety of a drug is inadequate considering the level of the recent veterinary and pharmaceutical sciences, the drug must be re-evaluated in accordance with the announcement of the Minister.
The re-evaluation is conducted by the OVDA. The NVAL supports the re-evaluation through screening work of scientific reports related to efficacy or safety of veterinary drugs. The post-marketing surveillance for the re-evaluation must also be performed based on the GPMSP. f) Manufacturers or importers of drugs or drug marketing companies shall not manufacture, import or sell a drug that is not as approved. When a faulty drag is identified by testing at the NVAL, the Minister will order the manufacturer or the importer to recall and discard the faulty drag.
Activities of the veterinary vaccine control laboratory
The NVAL and other vaccine control laboratories test veterinary vaccines for quality, efficacy and safety. There is some variation between countries as to the exact testing performed by the vaccine control laboratories. In many countries, including the USA, the responsibility for efficacy testing is given to the manufacturer. The testing performed in Japan is fairly typical of most countries. The following is a list of the activities carried out by the NVAL which will serve as an example of the activities of a veterinary vaccine control laboratory: Details of the more important of these functions will be discussed in the next section.
National assay of vaccines
Even the slightest error at the manufacturing stage may affect the quality of vaccines. Manufacturers are responsible for performing tests to determine the quality, safety and efficacy of their product and to ensure that there are no errors in the manufacturing process. In addition, vaccines are designated as drugs or biological products in most countries and are subject to national assay by the Ministry of Agriculture laboratory. In Japan, the NVAL is designated as the assaying laboratory for biological products. An assay is performed on each batch of product according to the assay standard (3). The assay standards were established for 154 kinds of vaccine as of 1 December 1997. The NVAL and vaccine control labora tories in many countries perform assays on every vaccine sold for livestock, poultry, companion animals or cultured fishes. The Assay Division I of the NVAL has seven sections, and each section tests different types of vaccines (Table I ). The tests performed by the NVAL and by the vaccine control laboratories in many other countries are for sterility, safety and potency on all vaccines. Live virus vaccines are tested for extraneous agents and virus content. Live bacterial vaccines are also tested for spore or colony count.
In Japan, the manufacturer is notified by the MAFF of the number of samples that will be needed for the assays and the fee that the manufacturer will have to pay for the assays (4). The pharmaceutical inspector of the prefectural government will collect the samples required from each batch of vaccine and send them to the NVAL. In some countries, a sample of product is collected and sent to the vaccine control laboratory; but not all batches are tested by the laboratory. To use Newcastle disease vaccine as an example, the manufacturer in Japan must perform twelve types of tests on live vaccines; eight of these tests are repeated by the NVAL. In the case of inactivated Newcastle disease vaccine, nine tests are carried out by the manufacturer and three are repeated by the NVAL (Table II) .
In Japan, a quality test is not conducted on the master seed by the NVAL: this is the responsibility of the manufacturer. In many countries, the master seed must be submitted to the vaccine control laboratory and tested before production of the vaccine can be initiated.
In Japan, when a batch of vaccine passes the national assay, a certification label is provided by the NVAL that is to be put on every package before it is marketed. Other countries have other methods to certify that a batch of vaccine has passed the national assay. In other words, vaccines cannot be released without passing the national assay. In Japan, a total of 703 and 711 batches of vaccines were assayed in the fiscal years 1995 and 1996, respectively. Five cases in 1995 and six cases in 1996 were rejected as a result of the national assay. The reasons for rejection were nonconformity on the safety test (five batches), potency (three batches), viral content (two batches) or miscellaneous bacteria (one batch). These vaccines were disposed of by the manufacturer or the importer. 
Distribution of reference products for the test of vaccines
In most countries, the use of some reference products is prescribed in the minimum requirements for licensing biological products for animal use. These products help maintain a high degree of accuracy in manufacturing and quality control. The NVAL provides these reference products for production or quality testing of vaccines as shown in Table III . These products (bacterial or viral strains, reference vaccine, etc.) are distributed to manufacturers or others according to the established policies (11) . New reference products will be added to the list after they have been validated by research conducted at the vaccine control.
Requested examination
The NVAL performs a test at the request of manufacturers or other persons based on the rules established by the Minister of Agriculture (12) 
Inspection for good laboratory practices
In 1988, the GLP system relating to drugs for animal use was established to secure confidence in the data attached with the application of approval or re-evaluation of a drug in Japan. GLP procedures are now standard for vaccine production throughout the world.
The NVAL is responsible for GLP inspection in Japan. The veterinary control laboratory in many countries has this Seed for product responsibility. Veterinarians or pharmacists of the NVAL carry out the inspections. They check that laboratories which perform the safety test of the vaccine on target animals conform to the standard GLP system.
Technical training
The NVAL and other vaccine control laboratories provide technical training on the testing of drugs and on the inspection of manufacturers, importers and drug marketing companies to prefectural government personnel, as well as technical guidance to the quality control staff of manufacturers or importers of drugs for animal use. In addition, the vaccine control laboratories accept governmental officers from foreign countries for training.
Public relations
The NVAL produces two publications: an Annual Report of the NVAL (in Japanese with a summary in English, issued from I960),'and News of the NVAL (which is a monthly publication in Japanese, dating from April 1974).
The NVAL also set up a site on the world-wide web in 1996. This site offers scientific reports and information about veterinary drugs through the internet (http://www.nval. go.jp).
International activity for veterinary vaccine control laboratories
The increased movement and the international marketing of veterinary vaccines have stimulated an interest in the harmonisation of regulatory requirements to facilitate this trade. Consequently, the work of the International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) was initiated in April 1996 by the Office International des Epizooties (OIE). The Ministry of Agriculture, Forestry and Fisheries of Japan is a member of the VICH, along with the European Union and the USA. A technical review on quality, safety or efficacy of veterinary drugs is under way. A new working group on quality monitoring of biological products will be set up to discuss the following topics: a) extraneous agents b) mycoplasma c) moisture and formaldehyde.
It is important that the veterinary vaccine control laboratories improve quality control of distributed products. The OIE is expected to facilitate this work.
Conclusions
Activities of the veterinary vaccine control laboratory for assuring quality, efficacy, potency and safety of veterinary vaccines have been reviewed. There is a need to harmonise technical requirements and to develop technical levels of quality control of veterinary vaccines with the advance of international trade. This international co-operation work should be guided by the OIE. It is hoped that the exchange of information will help to develop the international standardisation of veterinary vaccines. 
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Actividades de los laboratorios veterinarios de control de vacunas
H. Makie
Resumen
El autor repasa las actividades propias de un laboratorio veterinario de control de vacunas. Utilizando a modo de ejemplo el Laboratorio Nacional de Ensayos Veterinarios de Japón (National Veterinary Assay Laboratory: NVAL), describe un sistema de control de calidad de las vacunas veterinarias. Los laboratorios de este tipo someten a prueba las vacunas veterinarias y realizan estudios para perfeccionar los métodos de prueba e incrementar su calidad, eficacia y nivel de seguridad. La responsabilidad primera del laboratorio de control de vacunas veterinarias reside en probar vacunas para su empleo en el territorio nacional. Dichos laboratorios intervienen también en la distribución de materiales de referencia, además de llevar a cabo exámenes, inspecciones de otros establecimientos para velar por la aplicación de buenas prácticas de laboratorio, tareas de formación técnica y otros cometidos que quiera encomendarle el Ministerio de Agricultura. Junto a laboratorios de control veterinario de otros países, el NVAL participó en el grupo de la Cooperación Internacional sobre Armonización de Productos Veterinarios (International Co-operation on Harmonisation of Veterinary Medicinal Products) cuyo trabajo, iniciado por la Oficina Internacional de Epizootias, perseguía la armonización de los requisitos técnicos para el registro de vacunas veterinarias.
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